Activist Investors Push for Board Overhaul at Evogene After Building 16.7% Stake
EVGN sits 32% above its 52-week low of $0.37 on elevated volume (21× avg).
Summary
An activist group has acquired a 16.7% stake in Evogene and is demanding a special meeting to replace most of the board, criticizing the company's financial performance and dilution.
Key Events · Executive and Board Changes · EVGN
-
Activist Group Acquires 16.7% Stake
On July 10, 2026, L.I.A. Pure Capital and Invest Pro purchased 1,970,000 shares at $0.49, giving them a combined 16.7% stake and the ability to call a special meeting.
-
Demand to Replace Five of Six Directors
The activists are calling for the removal of Chairman Nir Nimrodi and four other directors, while supporting CEO Ofer Haviv. They propose four new nominees with backgrounds in finance, governance, and science.
-
Criticism of Financial Performance and Dilution
As evidence of board failure to create shareholder value, the group points to an 86% revenue decline in Q1 2026 to $0.3M, a $5.9M net loss, and repeated dilutive financings.
-
Interim Restrictions Sought
Until the special meeting, the activists demand that the company refrain from material transactions, dilutive offerings, board appointments, or poison pills, and they have offered to provide bridge financing if needed.
Analysis · EVGN · Industrial Applications And Services
L.I.A. Pure Capital and Invest Pro, which together hold a 16.7% stake, are demanding a special meeting to replace five of six directors, citing persistent losses, an 86% revenue drop in Q1 2026, and repeated shareholder dilution. While they support CEO Ofer Haviv, they want new directors with financial, governance, and scientific expertise. The activists also seek to restrict major corporate actions until the meeting. This direct challenge to the board's strategy could trigger a proxy fight, with significant implications for the company's direction and capital allocation.
How filings like this one have moved
In the 30 days to Aug 24, 2026, 44% of the 972 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.11%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, EVGN was trading at $0.49 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $6.1M. The 52-week trading range was $0.37 to $1.50. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.